There is currently one validated epigenetic test commercially available, ConfirmMDx (MDxHealth, Irvine, CA, USA), designed for diagnostic rather than prognostic purposes, that uses the methylation profile of three genes (APC, RASSF1, GSTP1) to detect cancer in histologically negative biopsies [56]. This evidence concerns the gene GSTP1 and cancer.